Concerns about independence of US guidelines for treatment of childhood obesity

The American Academy of Pediatrics (AAP) is not transparent about the creation of its guideline for childhood obesity medication. The scientific substantiation appears to be limited, and the AAP appears to have financial ties with pharmaceutical companies that produce this medication, which were not mentioned in the guidelines. This is the conclusion of researchers from Amsterdam UMC, VU Amsterdam, the University of California and the University of Colorado, which is published today.

Read More

Tocolytic drugs that inhibit contractions after 30 weeks of pregnancy has no effect on a baby's health

The use of tocolytic drugs in cases of threatened premature birth after 30 weeks of pregnancy does not improve the baby’s health. “There was no benefit but also no harm done," says Amsterdam UMC PhD-student Larissa van der Windt. The results of the largest study concerning the effectiveness of tocolytic drugs on the health of babies, led by Amsterdam UMC, were published today in The Lancet.

Read More